FibroGen, Inc.
FGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,579 | -$284,232 | -$293,654 | -$290,023 |
| Dep. & Amort. | $2,692 | $9,930 | $10,604 | $14,809 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $25,215 | $50,767 | $65,601 | $71,161 |
| Change in WC | -$117,459 | -$119,687 | $70,430 | $60,083 |
| Other Non-Cash | -$868 | $28,201 | $1,086 | $61,738 |
| Operating Cash Flow | -$137,999 | -$315,021 | -$145,933 | -$82,232 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$266 | -$2,519 | -$3,741 | -$5,186 |
| Net Acquisitions | $1,046 | $656 | $0 | $0 |
| Inv. Purchases | -$8,628 | -$251,830 | -$164,023 | -$484,144 |
| Inv. Sales/Matur. | $133,841 | $407,350 | $291,874 | $87,358 |
| Other Inv. Act. | $0 | $0 | -$34,994 | -$25,000 |
| Investing Cash Flow | $125,993 | $153,657 | $89,116 | -$426,972 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$40 | $73,594 | -$538 | -$5,892 |
| Stock Issued | $139 | $48,407 | $4,184 | $12,701 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,230 | $0 | $0 | $0 |
| Other Fin. Act. | $1,876 | $748 | $43,130 | -$7,372 |
| Financing Cash Flow | -$255 | $122,749 | $46,776 | -$563 |
| Forex Effect | $751 | -$3,397 | -$5,482 | $2,597 |
| Net Chg. in Cash | -$11,510 | -$42,012 | -$15,523 | -$507,170 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113,688 | $155,700 | $171,223 | $678,393 |
| End Cash | $102,178 | $113,688 | $155,700 | $171,223 |
| Free Cash Flow | -$138,265 | -$317,540 | -$184,674 | -$112,418 |